Cardiology Research Review, Issue 133

In this issue:

Treat post-STEMI patients regardless of risk factors
Most patients hospitalised with HFrEF are candidates for dapagliflozin
Empagliflozin in patients with HFrEF and volume overload
Effects of omega-3 fatty acids and vitamin D on incident AF
Does socioeconomic status affect outcomes in the first year after MI?
Prognostic significance of suboptimal pharmacotherapy after ACS
Antihypertensives and statin therapy for primary stroke prevention
Aspirin vs clopidogrel for chronic maintenance monotherapy after PCI
Ischaemic event reduction with rivaroxaban after peripheral arterial revascularisation
Left atrial appendage occlusion during cardiac surgery to prevent stroke

Please login below to download this issue (PDF)

Subscribe